Glucagon Kit
Product Images NDC 0378-8067

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 0378-8067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram of glucagon showing a linear sequence of amino acids numbered 1 through 29 from the amino (H2N) to carboxyl (COOH) terminus. Each amino acid is represented by its three-letter abbreviation inside circles, connected in a curved chain.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting blood glucose concentrations (mg/dL) over time (hours). The graph shows a rise in blood glucose levels peaking before one hour, followed by a decline and stabilization around 80 mg/dL from approximately 1.5 to 4 hours.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing glucagon concentration (ng/mL) over time (hours). The graph depicts a peak concentration reached before 1 hour, followed by a gradual decline in glucagon levels until approximately 4 hours. Error bars indicate variability around each data point.*

FDA Label Image

Figure A (Image 04)

An exploded instructional diagram of a Glucagon kit by Mylan Pharmaceuticals, showing labeled components including a vial containing powder with a rubber stopper and flip-off seal, a needle protector, a prefilled syringe containing diluent with an attached needle, a backstop with a plastic clip, and a plunger.*

FDA Label Image

Figure B (Image 05)

An instructional illustration showing a hand gripping a syringe or similar device with the thumb positioned to push the plunger upward as indicated by a black arrow. The image likely demonstrates how to operate the device included in the Glucagon kit by Mylan Pharmaceuticals.*

FDA Label Image

Figure C (Image 06)

An instructional illustration showing two hands preparing an injection. One hand holds a vial while the other hand inserts a syringe needle into the vial, indicated by a downward arrow. This image demonstrates the step of drawing medication into a syringe from a vial.*

FDA Label Image

Figure D (Image 07)

An instructional line drawing showing a hand rotating a small vial or container in a clockwise direction, indicated by an arrow. This illustration likely demonstrates a step in preparing or mixing a product from the Glucagon kit by Mylan Pharmaceuticals Inc.*

FDA Label Image

Figure E (Image 08)

An instructional line drawing illustrating the assembly or preparation of a medication syringe or vial. The image shows a hand holding a vial or syringe component, with an arrow indicating a downward action, likely depicting step-by-step use or preparation guidance for administering a drug.*

FDA Label Image

Box Label (Image 09)

Text panel from a Glucagon injection kit label, providing instructions for use, dosage information, storage conditions, and manufacturer details. It clarifies the kit contents including a single-dose vial and syringe with diluent, usual dosing, mixing instructions, and storage at controlled room temperature with no returns on unused portions. The labeler is Mylan Pharmaceuticals Inc., made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.